Ying Cao

Ying Cao

Auto-generated profile, based on publicly available information

Ying Cao

Department of Clinical Laboratory, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
XTXiaoyuan Tian
Xiaoyuan Tian
ZQZhenan Qu
Zhenan Qu
YCYing Cao
Ying Cao
BZBo'cheng Zhang
Bo'cheng Zhang
Introduction: The aim of this meta-analysis was to evaluate the efficacy and safety of mesenchymal stem cells (MSCs) for the treatment of knee osteoarthritis (OA). Methods: The PubMed, Embase, Cochrane Central Register of Controlled Trials, Scopus and Web of Science databases were searched from inception to May 6, 2024 to identify randomized controlled trials that compared MSCs and placebo or other nonsurgical approaches for treating OA. Two investigators independently searched the literature and extracted data, and conventional meta-analyses were conducted with Review Manager 5.3. The outcomes included pain relief, functional improvement, and risk of adverse events (AEs).Results: A total of 18 articles were included. Overall, MSCs were superior to placebo in terms of relieving pain and improving function at the 12-month follow-up. However, the differences in treatment-related AEs were not significant.Conclusion: MSCs may relieving pain and improving function of OA. The limitations of this study include the high heterogeneity of the included studies. Additionally, the follow-up time in the included studies was relatively short, so more clinical trials are needed to predict the long-term efficacy and safety of MSCs.Systematic review registration: https://doi.org/10.17605/OSF.IO/5BT6E, identifier CRD42022354824.

1 January 2025 in Depression and Anxiety
Verified
Journal Article
Open access
YCYing Cao
Ying Cao
XLXuguang Li
Xuguang Li
JGJing Gao
Jing Gao
NZNan Zhang
Nan Zhang
GZGuoqian Zhang
Guoqian Zhang
SLShen Li
Shen Li
Background: The link between white blood cells (WBC) and depression has been studied, but the causal relationship remains unclear. This study aimed to elucidate the potential bidirectional causal links between six specific WBC count features and depression using a two‐sample Mendelian randomization (MR) analysis, leveraging summary statistics from genome‐wide association studies (GWAS). Method: The dataset on depression ( N = 406,986) was sourced from the FinnGen database, while the dataset on WBC ( N = 563,085) was obtained from a combined dataset of Blood Cell Consortium (BCX) and UK Biobank. The MR analyses employed include inverse variance weighted (IVW), MR‐Egger, weighted median, contamination mixture method (conmix), and constrained maximum likelihood‐based Mendelian randomization (cML‐MA). A threshold p < 0.05 after false discovery rate (FDR) correction was set as the criterion for causality based on IVW. Results: Reverse MR analysis indicated a causal relationship where depression leads to an increase in overall WBC count (IVW beta = 0.031, p = 0.015, p FDR = 0.044) and specifically in basophil count (IVW beta = 0.038, p = 0.006, p FDR = 0.038), with a marginally significant impact on lymphocyte count (beta = 0.029, p = 0.036, p FDR = 0.071). Furthermore, forward MR analysis suggested a potential role of monocyte count in decreasing depression risk ( p = 0.028), though this association did not retain statistical significance after FDR correction. Conclusion: These findings suggest that depression may causally influence the immune system by elevating overall WBC and basophil counts, with a marginally significant increase in lymphocyte levels. Conversely, higher monocyte count might confer some protection against depression, albeit with less statistial certainty. This study provides novel insights into the complex interplay between depression and immune function.